查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球福利導管市場-2022-2029
市場調查報告書
商品編碼
1143417

全球福利導管市場-2022-2029

Global Foley Catheter Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

在預測期間（2022-2029 年），Foley 導管市場預計將以 6.2% 的高複合年增長率增長。

留置式 (Foley) 導管是一種封閉的無菌系統，允許將保留球囊和導管插入尿道或恥骨上，以便通過膀胱引流。 Foley導尿管是最常見的用於從膀胱排出尿液的導尿管之一。這種細的、無菌的、柔性的管子用於各種慢性和急性疾病，包括尿失禁和良性前列腺增生 (BPH)。這些導管僅建議在 30 天內短期使用。

市場動態

由於尿瀦留、良性前列腺增生 (BPH)、尿失禁和前列腺癌等泌尿系統疾病的患病率不斷上升，全球 Foley 導管市場正在擴大。

此外，全球老年人口數量的增加預計將成為市場增長的驅動力。

尿失禁是普通人群，尤其是老年人的常見疾病，會降低生活質量。世界衛生組織 (WHO) 認為 65 歲以上的人年齡較大，聯合國認為 60 歲以上的人年齡較大。世界人口正在迅速老齡化，目前65歲以上人口為7.03億，預計到2050年這一數字將達到15億。尿失禁是普通人群，尤其是老年人的常見疾病，會降低生活質量。據說，10-20% 的女性和 77% 的療養院女性患有尿失禁。

此外，在許多針對老年女性的研究中都觀察到了尿失禁，在美國研究中的總體頻率為 14%。在歐洲國家進行的一項研究估計，尿失禁的患病率為 37%。根據在亞洲國家進行的調查，老年人尿失禁的患病率在亞洲為 13%，在非洲為 45.3%。在中東國家進行的一項調查報告稱，尿失禁的患病率為 52%。因此，全球對 Foley 導管的需求增加。因此，從上述陳述來看，預計市場將在預測期內受到驅動。

與 Foley 導管相關的並發症預計將在預測期內得到抑制。

這個過程很痛苦。插入和拔出潤滑不良的導管會在尿道壁和器械表面之間產生摩擦。即使一開始不會感到不舒服，繼續使用也會使尿道變窄，導致出血和感染。應特別注意避免尿石症和 CAUTI 的不良影響。此外，不利的稅收制度、新興國家不利的報銷做法以及增加的產品故障和召回預計將在預測期內阻礙市場。

行業分析

Foley 導管市場根據各種行業因素（包括未滿足的需求、定價分析、供應鏈分析和監管分析）對市場進行深入分析。

細分分析

預計乳膠部分將在 Foley 導管市場佔有最大的市場份額。

乳膠細分市場將在 2021 年佔據最大的市場份額。這部分受益，因為由純乳膠製成的導管更便宜。水凝膠、矽膠和聚四氟乙烯塗層使這些導管柔軟、潤滑、可靠、高度靈活、嵌入更少、刺激性更小，並且可以提高患者的安全性。預計塗層乳膠導管很快就會有很高的需求，因為它們可以最大限度地減少細菌粘附和包皮。例如，Cardinal Health 生產 Dover 水凝膠塗層乳膠 Foley 導管，以方便插入並保護患者的尿道。因此，增加了對基於乳膠的 Foley 導管的需求。因此，從上述描述來看，市場細分在預測期內佔據了最大的市場份額。

競爭格局

Foley 導管市場的主要關鍵參與者是： B. Braun Melsungen AG、康樂保公司、Teleflex Incorporated、BD、Cardinal Health、美敦力、SunMed、BACTIGUARD 等。

B. Braun Melsangen AG

B.Braun 是一家德國醫療器械和藥品製造商。 B.Brown 的產品線由 5,000 種產品組成，其中 95% 是內部製造的。公司的產品組合包括輸液、營養和疼痛產品、輸液泵和系統、手術器械、縫合材料、髖關節和膝關節植入物、透析機和配件、造口術、消毒和傷口護理產品。它通過五個部門運營：醫院護理、Aesculap、B.Brown Avitam、門診市場 (OPM) 和其他分銷。 B.Brown 在 64 個國家/地區開展業務，並在醫療保健行業的 18 個治療領域開發產品。

產品組合

Urimedcas Foley Neraton：Urimedcas Foley Nelaton 導管是一種分叉的矽膠 Foley 導管，適用於常規膀胱引流。

功效

  • 急性和慢性尿瀦留
  • 為因神經系統疾病導致排尿障礙或感覺喪失而影響排尿而排尿困難的患者保持持續排尿。
  • 需要準確測量危重患者的尿量
  • 特定外科手術的圍手術期
  • 接受泌尿外科手術或其他泌尿系統附近結構手術的患者
  • 預計會延長手術時間的患者
  • 術中尿量監測的必要性
  • 幫助大小便失禁患者□骨或會陰部的開放性傷口癒合
  • 需要長期制動的患者（如胸腰椎不穩定、骨盆骨折等多發性外傷等）
  • 允許膀胱沖洗/陰道沖洗。
  • 促進節制和保持皮膚完整性（如果保守治療失敗）
  • 根據需要提高臨終關懷的舒適度
  • 頑固性尿失禁的管理

全球福利導管市場報告提供對超過 45 個市場數據表和超過 40 個數據的訪問。

內容

第1章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

  • 按產品類型劃分的市場細分
  • 按應用劃分的市場細分
  • 按材料劃分的市場細分
  • 最終用戶的市場細分
  • 按地區劃分的市場細分

第 4 章 Foley 導管市場 - 市場動態

  • 市場影響因素
  • 驅動程序
    • 尿失禁和 BPH 增加
    • Foley 導管的技術進步
  • 約束因素
    • 嚴格的產品審批規定
  • 商機
  • 影響分析

第5章行業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析
  • 產品開發
  • 未滿足的需求

第 6 章按產品類型

  • 兩種方式
  • 三向
  • 四個方向

第 7 章材料

  • 乳膠
  • 矽膠
  • 其他

第 8 章按應用程序

  • 尿失禁
  • 良性前列腺增生 (BPH)
  • 手術
  • 其他

第 9 章，最終用戶

  • 醫院
  • 長期護理醫療機構
  • 其他

第 10 章按地區劃分

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 11 章競爭格局

  • 競爭場景
  • 市場情況/份額分析
  • 併購分析

第 12 章公司簡介

  • B.Braun Melsungen AG
    • 公司概況
    • 產品組合和描述
    • 主要亮點
    • 財務摘要
  • Coloplast Corp
  • Teleflex Incorporated
  • BD
  • Cardinal Health
  • Medtronic
  • SunMed
  • BACTIGUARD（*List Is Not Exhaustive）

第13章 DataM

簡介目錄
Product Code: DMMD1472

Market Overview

Foley Catheter Market is expected to grow at a high CAGR of 6.2% during the forecasting period (2022-2029).

An indwelling (Foley) catheter is a closed sterile system with a retention balloon and a catheter inserted either through the urethra or suprapubically to allow for bladder drainage. Foley catheters are one of the most common urinary catheters used for draining urine from the bladder. These thin, sterile, flexible tubes are used for various chronic and acute conditions, including urinary incontinence and benign prostatic hyperplasia (BPH). These catheters are recommended only for short-term use, for less than 30 days.

Market Dynamics

The global foley catheters market is growing owing to the rising prevalence of urological diseases, such as urinary retention, benign prostate hyperplasia (BPH), urinary incontinence, and prostate cancer.

The increasing elderly patient population globally is expected to drive market growth.

Urinary incontinence is a common condition in the general population, particularly the older adult population, which reduces the quality of life. The World Health Organization (WHO) considers persons 65 or older to be older adults, while the United Nations considers those 60 years or older to be older adults. The world's population is quickly aging, with 703 million individuals over the age of 65 presently, and this figure is expected to rise to 1.5 billion by 2050. Urine incontinence is a prevalent disorder in the general population, particularly among older people, and it lowers the quality of life. Ten to twenty percent of all women and 77% of women in nursing homes have urinary incontinence.

Moreover, Urinary incontinence has been observed in much research among older women, with an overall frequency of 14% in US studies. The prevalence of urine incontinence has been estimated to be 37% in research conducted in European countries. In research conducted across Asia, the prevalence of urine incontinence in older persons was 13% in Asia and 45.3% in Africa. The prevalence of urinary incontinence was reported to be 52% in a study conducted in Middle Eastern countries. Therefore, it has increased the demand for foley catheters worldwide. Thus, from the above statements, the market is expected to drive in the forecast period.

Complications associated with the foley catheter are expected to get hampered in the forecast period.

The procedure is painful. It entails inserting and removing insufficiently lubricated catheters, causing friction between the urethral walls and the device's surface. These may not be unpleasant at first, but continued usage may cause urethral constriction, resulting in bleeding and infection. Extra caution is essential to avoid the negative effects of UTIs and CAUTIs. Moreover, unfavorable tax policies, unfavorable reimbursement practices in developing nations, and increased product failures and recalls are the factors the market is expected to hamper in the forecast period.

Industry Analysis

The foley catheter market provides in-depth analysis of the market based on various industry factors such as unmet needs, pricing analysis, supply chain analysis, regulatory analysis etc.

Segment Analysis

Latex segment is expected to hold the largest market share in the foley catheter market.

The latex segment accounted for the largest market share in 2021. The segment is benefiting because catheters made of pure latex are not expensive. These catheters have hydrogel, silicone, and Teflon coatings that make them soft, lubricious, reliable, and highly flexible; they provide increased patient safety with less encrustation and irritation. The ability of coated latex catheters to minimize bacterial adhesion and encrustation is predicted to increase demand shortly. For instance, Cardinal Health manufactures the Dover Hydrogel Coated Latex Foley Catheter to make insertion easier and to protect the patient's urethra. Therefore, it has increased the demand for latex-based foley catheters. Thus, from the above statements, the market segment accounted for the largest market share in the forecast period.

Competitive Landscape

Major key players in the foley catheter market are: B. Braun Melsungen AG, Coloplast Corp, Teleflex Incorporated, BD, Cardinal Health, Medtronic, SunMed and BACTIGUARD, among others.

B. Braun Melsungen AG:

B. Braun is a German manufacturer of medical and pharmaceutical devices. The B. Braun product line includes 5,000 items, 95 percent of which are manufactured by the company. The company's product portfolio includes infusion, nutrition, pain therapy products, infusion pumps and systems, surgical instruments, suture materials, hip and knee implants, dialysis equipment and accessories, ostomy, disinfection, and wound care products. The company operates its business through five divisions: hospital care, Aesculap, B. Braun Avitum, out-patient market (OPM) and other sales. B. Braun has a presence in 64 countries and develops products in 18 therapy fields of the healthcare industry.

Product Portfolio:

Urimed Cath Foley Nelaton: The Urimed Cath Foley Nelaton catheter is a two-way silicone Foley catheter indicated for routine bladder drainage.

Indication:

  • Acute and chronic urinary retention
  • Maintain a continuous outflow of urine for patients with voiding difficulties as a result of neurological disorders that cause paralysis or loss of sensation affecting urination,
  • Need for accurate measurement of urinary output in critically ill patients
  • Perioperative for selected surgical procedures
  • Patients undergoing urological surgery or other surgery on contiguous structures of the genitourinary tract
  • Anticipated prolonged duration of surgery
  • Need for intra-operative monitoring of urinary output
  • To assist in healing of open sacral or perineal wounds in incontinent patients
  • Patient requires long-term immobilization (e.g. potentially unstable thoracic or lumbar spine, multiple traumatic injuries such as pelvic fractures
  • To allow bladder irrigation/lavage
  • To facilitate continence and maintain skin integrity (when conservative treatment methods have been unsuccessful
  • To improve comfort for end of life care if needed
  • Management of intractable incontinence.

The global foley catheter market report would provide an access to an approx. 45+ market data table, 40+ figures.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet by Product Type
  • 3.2. Market Snippet by Application
  • 3.3. Market Snippet by Material
  • 3.4. Market Snippet by End-User
  • 3.5. Market Snippet by Region

4. Foley Catheters Market-Market Dynamics

  • 4.1. Market Impacting Factors
  • 4.2. Drivers
    • 4.2.1. Rising prevalence of urinary incontinence & BPH
    • 4.2.2. Technological Advancements in Foley Catheters
  • 4.3. Restraints
    • 4.3.1. Stringent regulations for product approvals
  • 4.4. Opportunity
  • 4.5. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Product developments
  • 5.6. Unmet Needs

6. By Product Type

  • 6.1. Introduction
  • 6.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type Segment
  • 6.3. Market Attractiveness Index, By Product Type Segment
    • 6.3.1. Two-way*
      • 6.3.1.1. Introduction
      • 6.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 6.3.2. Three-way
    • 6.3.3. Four-way

7. By Material

  • 7.1. Introduction
  • 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Segment
  • 7.3. Market Attractiveness Index, By Material Segment
    • 7.3.1. Latex*
      • 7.3.1.1. Introduction
      • 7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 7.3.2. Silicone
    • 7.3.3. Others

8. By Application

  • 8.1. Introduction
  • 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
  • 8.3. Market Attractiveness Index, By Application Segment
    • 8.3.1. Urinary Incontinence*
      • 8.3.1.1. Introduction
      • 8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 8.3.2. Benign Prostatic Hyperplasia (BPH)
    • 8.3.3. Surgery
    • 8.3.4. Others

9. By End-User

  • 9.1. Introduction
  • 9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User Segment
  • 9.3. Market Attractiveness Index, By End-User Segment
    • 9.3.1. Hospitals*
      • 9.3.1.1. Introduction
      • 9.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 9.3.2. Long-term Care Facilities
    • 9.3.3. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.7.1. U.S.
      • 10.2.7.2. Canada
      • 10.2.7.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.7.1. Germany
      • 10.3.7.2. U.K.
      • 10.3.7.3. France
      • 10.3.7.4. Italy
      • 10.3.7.5. Spain
      • 10.3.7.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.7.1. Brazil
      • 10.4.7.2. Argentina
      • 10.4.7.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.7.1. China
      • 10.5.7.2. India
      • 10.5.7.3. Japan
      • 10.5.7.4. Australia
      • 10.5.7.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. B. Braun Melsungen AG*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Coloplast Corp
  • 12.3. Teleflex Incorporated
  • 12.4. BD
  • 12.5. Cardinal Health
  • 12.6. Medtronic
  • 12.7. SunMed
  • 12.8. BACTIGUARD (*List Is Not Exhaustive)

13. DataM Intelligence

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us